KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Equity Average (2016 - 2026)

Idexx Laboratories has reported Equity Average over the past 16 years, most recently at $1.6 billion for Q4 2025.

  • For Q4 2025, Equity Average fell 1.46% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $1.6 billion, down 1.46%, while the annual FY2025 figure was $1.6 billion, 3.92% up from the prior year.
  • Equity Average for Q4 2025 was $1.6 billion at Idexx Laboratories, up from $1.5 billion in the prior quarter.
  • Over five years, Equity Average peaked at $1.6 billion in Q4 2024 and troughed at $466.5 million in Q3 2022.
  • A 5-year average of $1.1 billion and a median of $1.1 billion in 2023 define the central range for Equity Average.
  • Biggest five-year swings in Equity Average: skyrocketed 367.41% in 2021 and later crashed 37.95% in 2022.
  • Year by year, Equity Average stood at $722.7 million in 2021, then decreased by 24.96% to $542.4 million in 2022, then soared by 156.46% to $1.4 billion in 2023, then rose by 15.51% to $1.6 billion in 2024, then decreased by 1.46% to $1.6 billion in 2025.
  • Business Quant data shows Equity Average for IDXX at $1.6 billion in Q4 2025, $1.5 billion in Q3 2025, and $1.5 billion in Q2 2025.